Position
Essential Partners LLC in Editas Medicine, Inc.
Back to the book · All holders of EDIT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $299$2.05 → $2.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2025 | 713 | $1.57K | — | — | — | 0.0% |
| Q3 2025 | 713 | $2.47K | $3.47 | $905 | $0 | 0.0% |
| Q4 2025 | 713 | $1.46K | $2.05 | −$1.01K | $0 | 0.0% |
| Q1 2026 | 1.48K | $3.66K | $2.47 | $299 | $1.9K | 0.0% |